Hyuk Chul Kwon

Title: Hyuk Chul Kwon: Innovator in Pharmaceutical Chemistry

Introduction

Hyuk Chul Kwon is a notable inventor based in Suwon, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds and methods for drug preparation. With a total of 2 patents to his name, Kwon's work has had a meaningful impact on the industry.

Latest Patents

Kwon's latest patents include the "Montelukast 4-halobenzylamine salt and method for preparing montelukast sodium salt by using the same." This patent discloses a novel montelukast 4-halobenzylamine salt and a method for preparing a montelukast sodium salt using this compound. The method allows for the preparation of the montelukast sodium salt in the same reactor without requiring an additional obtaining process. In this method, the montelukast 4-halobenzylamine salt is represented by a specific formula where X can be F, Cl, Br, or I.

Another significant patent is the "Process for preparing voriconazole by using new intermediates." This process involves a Reformatsky-type coupling reaction between a ketone derivative and a pyrimidine derivative to obtain a compound. The method further includes reacting substituents with a hydrogen donor to produce racemic Voriconazole, followed by optical isolation to achieve high optical purity with cost-efficiency and high yield.

Career Highlights

Hyuk Chul Kwon has worked with reputable companies such as Dong Kook Pharm Co., Ltd and Dongkook Pharmaceutical Co., Ltd. His experience in these organizations has allowed him to refine his skills and contribute to various innovative projects in the pharmaceutical sector.

Collaborations

Kwon has collaborated with notable coworkers, including Man Dong Rho and Kyung Hoi Cha. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the quality of his work.

Conclusion

Hyuk Chul Kwon is a distinguished inventor whose contributions to pharmaceutical chemistry are noteworthy. His innovative patents and collaborations reflect his commitment to advancing the field. His work continues to influence the development of effective pharmaceutical solutions.